Pentostatin
- 1 October 1993
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 46 (4), 652-677
- https://doi.org/10.2165/00003495-199346040-00006
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Therapeutic alternatives in cutaneous T-cell lymphomaJournal of the American Academy of Dermatology, 1992
- Rat Brain Adenosine Deaminase After 2′‐Deoxycoformycin Administration: Biochemical Properties and Evidence for Reduced Enzyme Levels Detected by 2′‐[3H]Deoxycoformycin Ligand BindingJournal of Neurochemistry, 1992
- Antineoplastic Drugs in 1990Drugs, 1990
- Niacin prevents DNA strand breakage by adenosine deaminase inhibitorsBiochemical and Biophysical Research Communications, 1990
- Treatment of cutaneous T cell lymphoma with 2′-deoxycoformycin (pentostatin)Journal of the American Academy of Dermatology, 1988
- The effect of deoxycoformycin on bone marrow cells treated with adenosine and deoxyadenosine and hemopoietic growth factorsHuman Immunology, 1988
- Membrane phenotype and response to deoxycoformycin in mature T cell malignancies.BMJ, 1987
- Remissions in Hairy-Cell Leukemia with Pentostatin (2′-Deoxycoformycin)The New England Journal of Medicine, 1987
- Deoxycoformycin: A new chemotherapeutic agent of interest to dermatologistsJournal of the American Academy of Dermatology, 1985
- Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2′-deoxycoformycin, an adenosine deaminase inhibitorClinical Immunology and Immunopathology, 1981